WELL Health Reports Record Patient Visits and Total Care Interactions in FY 2024
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has reported record patient visits for fiscal year 2024, achieving 5.7 million total patient visits, representing a significant 32% year-over-year growth, with organic growth accounting for 30%.
The company's Canadian patient services business demonstrated exceptional performance, recording 3.125 million patient visits, marking a 35% year-over-year increase. The organic growth in Canadian operations was particularly strong at 32%, comprised of 26% same clinic sales growth and 6% absorption growth.
These preliminary operational results highlight WELL's success in leveraging its technology-enabled care model to drive strong organic growth across its enterprise, particularly in its Canadian Clinics division.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) ha riportato un numero record di visite dei pazienti per l'anno fiscale 2024, raggiungendo 5,7 milioni di visite totali, rappresentando una significativa crescita del 32% rispetto all'anno precedente, con una crescita organica che contribuisce per il 30%.
Il business dei servizi per pazienti canadesi dell'azienda ha dimostrato un'eccezionale performance, registrando 3,125 milioni di visite dei pazienti, segnando un aumento del 35% rispetto all'anno precedente. La crescita organica nelle operazioni canadesi è stata particolarmente forte al 32%, composta da un aumento del 26% nelle vendite delle stesse cliniche e un 6% di crescita per assorbimento.
Questi risultati operativi preliminari evidenziano il successo di WELL nell'utilizzare il suo modello di assistenza abilitato dalla tecnologia per guidare una forte crescita organica in tutta l'azienda, in particolare nella divisione Cliniche Canadesi.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) ha reportado un número récord de visitas de pacientes para el año fiscal 2024, alcanzando 5.7 millones de visitas totales, lo que representa un crecimiento significativo del 32% interanual, con un crecimiento orgánico que representa el 30%.
El negocio de servicios para pacientes en Canadá de la empresa mostró un rendimiento excepcional, registrando 3.125 millones de visitas de pacientes, marcando un aumento del 35% interanual. El crecimiento orgánico en las operaciones canadienses fue particularmente fuerte, alcanzando el 32%, compuesto por un crecimiento del 26% en las mismas clínicas y un 6% de crecimiento por absorción.
Estos resultados operativos preliminares destacan el éxito de WELL en aprovechar su modelo de atención habilitado por tecnología para impulsar un fuerte crecimiento orgánico en toda su empresa, particularmente en su división de Clínicas Canadienses.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF)는 2024 회계연도 동안 기록적인 환자 방문 수를 보고하며 570만 건의 총 환자 방문을 달성했습니다. 이는 전년 대비 32%의 상당한 성장률을 나타내며, 유기적 성장은 30%를 차지합니다.
회사의 캐나다 환자 서비스 사업은 뛰어난 성과를 보여주며 312.5만 건의 환자 방문을 기록하였고, 이는 전년 대비 35% 증가한 수치입니다. 캐나다 사업의 유기적 성장은 특히 강력하여 32%에 달하며, 이는 26%의 동일 클리닉 매출 성장과 6%의 흡수 성장으로 구성됩니다.
이러한 초기 운영 결과는 WELL이 기술 기반의 치료 모델을 활용하여 기업 전반에 걸쳐 강력한 유기적 성장을 이끌어내는 데 성공했음을 강조하며, 특히 캐나다 클리닉 부문에서 두드러집니다.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) a rapporté un nombre record de visites de patients pour l'exercice 2024, atteignant 5,7 millions de visites totales, représentant une croissance significative de 32 % d'une année sur l'autre, avec une croissance organique représentant 30 %.
L'activité de services aux patients au Canada de l'entreprise a fait preuve d'une performance exceptionnelle, enregistrant 3,125 millions de visites de patients, marquant une augmentation de 35 % d'une année sur l'autre. La croissance organique des opérations canadiennes a été particulièrement forte à 32 %, composée de 26 % de croissance des ventes dans les mêmes cliniques et de 6 % de croissance par absorption.
Ces résultats opérationnels préliminaires mettent en évidence le succès de WELL à tirer parti de son modèle de soins habilité par la technologie pour générer une forte croissance organique dans l'ensemble de son entreprise, en particulier dans sa division des cliniques canadiennes.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) hat für das Geschäftsjahr 2024 rekordverdächtige Patientenbesuche gemeldet und 5,7 Millionen Gesamtergebnisse erreicht, was einem signifikanten Wachstum von 32% im Vergleich zum Vorjahr entspricht, wobei das organische Wachstum 30% ausmacht.
Das kanadische Patientenservicegeschäft des Unternehmens zeigte eine außergewöhnliche Leistung mit 3,125 Millionen Patientenbesuchen, was einen Anstieg von 35% im Vergleich zum Vorjahr darstellt. Das organische Wachstum in den kanadischen Betrieben war besonders stark bei 32%, bestehend aus 26% Wachstum bei den gleichen Kliniken und 6% Wachstum durch Übernahme.
Diese vorläufigen Betriebsergebnisse unterstreichen den Erfolg von WELL, sein technologiegestütztes Pflege-Modell zu nutzen, um ein starkes organisches Wachstum im gesamten Unternehmen voranzutreiben, insbesondere in der Abteilung der kanadischen Kliniken.
- Record 5.7M total patient visits with 32% YoY growth
- Strong 30% organic growth in total patient visits
- Canadian operations achieved 35% YoY growth with 3.125M visits
- Impressive 26% same clinic sales growth in Canadian operations
- None.
- WELL delivered more than 5.7 million patient visits in fiscal 2024 representing YoY growth of
32% driven mostly by organic growth of30% - WELL
Canada 's patient services business led its overall growth with 3.125 million patient visits representing YoY growth of35% growth and organic growth of32% - WELL
Canada 's organic growth for patient services was comprised of26% same clinic sales growth and6% in absorption growth
Hamed Shahbazi, CEO of WELL, commented "Our Canadian Clinics underpinned by our technology enabled care model continues to lead the way in driving strong organic growth for the Company enterprise wide. We are very proud of and grateful to the healthcare providers and technologists working together to drive the best patient outcomes possible."
2024 | 2023 | Y/Y | Organic | |
Canada Patient Visits | 3,125,011 | 2,312,799 | 35 % | 32 % |
US Patient Visits | 2,576,557 | 2,013,613 | 28 % | 28 % |
Total Visits | 5,701,568 | 4,326,412 | 32 % | 30 % |
Technology Interactions(1) | 2,660,911 | 1,881,114 | 41 % | 41 % |
Billed Provider Hours(2) | 354,402 | 164,719 | 115 % | 115 % |
Total Interactions | 8,716,881 | 6,372,245 | 37 % | 34 % |
WELL Canada Clinics Annual Growth Breakdown
Y/Y | |
Same Clinic | +26 % |
Absorption | +6 % |
Total Organic | +32 % |
Inorganic Growth | +3 % |
Total Growth | +35 % |
Footnotes:
- Technology Interactions means the total number of bookings facilitated by certain technology platforms including OceanMD, Insig, and Adracare.
- Billed Provider Hours means the hours that providers bill under RADAR Healthcare Providers which is owned and operated by WELL's CRH Medical Subsidiary.
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 41,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more about the Company, please visit: www.well.company.
Forward Looking Statements
This news release contains "Forward-Looking Information" within the meaning of applicable Canadian securities laws, including, without limitation the expectation that patient visits and Total Interactions will continue to lead the way in driving strong organic growth for the Company enterprise wide. Forward-Looking Information is based on a number of estimates and assumptions are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond WELL's control, which could cause actual results and events to differ materially from those disclosed in this news release. Forward-Looking Information generally can be identified by the use of forward-looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe", "goal" or "continue", or the negative thereof or similar variations. Forward-Looking Information involves known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information is not a guarantee of future results or performance. WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL's control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including, but not limited to: new technologies functioning as expected; customers adopting and using new technologies and services as expected; the need to develop increasingly innovative products and services; competition in the industry; the stability of general economic and market conditions; WELL's ability to comply with applicable laws and regulations; WELL's continued compliance with third party intellectual property rights; direct and indirect material adverse effects from adverse market conditions; risks inherent in the primary healthcare sector in general; regulatory and legislative changes; litigation risk; that future results may vary from historical results; that market competition may affect the business, results and financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at www.sedarplus.ca, including its most recent Annual Information Form and its most recent Management, Discussion and Analysis. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.
View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-reports-record-patient-visits-and-total-care-interactions-in-fy-2024-302415509.html
SOURCE WELL Health Technologies Corp.
FAQ
What was WELL Health's (WHTCF) total patient visit growth in FY 2024?
How many patient visits did WELL Health's Canadian operations record in 2024?
What was the organic growth breakdown for WELL Health's (WHTCF) Canadian patient services in 2024?
How did WELL Health's (WHTCF) Canadian clinics perform in terms of organic growth for FY 2024?
